Organization (Academic)
Stockholm University
ClinicalTrials.gov lists Stockholm University as lead sponsor of 25 trials.
Search trials, drugs, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Trials started per year with this organization as sponsor or collaborator, 1990 onward. The series also counts trials where the organization is a collaborator; the lead-sponsor trial count does not.
2026 is partial: 6 registered with a 2026 start date. The hollow diamonds on the dashed line are a forecast of the full-year count, planned starts included: about 8 in 2026 and about 7 in 2027, the average of the 24 months through September, counted as registered and carried forward. The columns, the lighter one included, count trials registered so far with a start date in the year, planned starts included; the forecast looks ahead to the count for the whole year, so it is not the same measure. This method has not been backtested on organizations. In backtests on conditions with as many trial starts a year as this organization (5 to 20), forecasts made part-way through the year were typically off by about 28 percent and ran about 20 percent low against the count later registered; forecasts made before the year began were off by about 39 percent and ran about 37 percent low against the count later registered. These figures rest on a few years of history (target years from 2018 to 2025, varying by figure), place each condition as it is mapped today rather than as it was then, and score against a count for the newest year that was still being revised. Only condition series were scored.
This page covers Stockholm University: 25 lead-sponsored trials and 1 legal-entity registration.
Disease areas (48)
Shown in this order: most trials first.
| Disease area | Trials |
|---|---|
| Anxiety Disorders | 15 |
| Phobia, Social | 7 |
| Autism Spectrum Disorder | 5 |
| Sleep Initiation and Maintenance Disorders | 4 |
| Disruptive, Impulse Control, and Conduct Disorders | 3 |
Showing 5 of 48 disease areas.
Trials by start year as sponsor or collaborator (20)
Shown in this order: most recent first. 2026 is partial: trials registered with a 2026 start date so far, not a full year.
Show the table of trials by start year as sponsor or collaborator
| Year | Trials started |
|---|---|
| 2026 (partial year) | 6 |
| 2025 | 6 |
| 2024 | 7 |
| 2023 | 3 |
| 2022 | 7 |
| 2021 | 9 |
| 2020 | 5 |
| 2019 | 7 |
| 2018 | 2 |
| 2017 | 2 |
Showing 10 of 20 years.
Recruitment duration, a model prediction: none of the 25 trials evaluated at the 2026-10-09 snapshot is predicted and still running. Source: ClinicalTrials.gov / AACT (CTTI), public domain.
Sponsor delivery record (1)
Enrollment hit target: the share of this sponsor's lead-sponsored trials whose actual enrollment reached the planned enrollment. On time: the share whose actual primary completion date was no later than the planned date. Each share counts only trials where we observed an estimated figure before the actual one, and n is that number of trials. Below 5 trials the count is shown as a fraction, not a percentage.
| Enrollment | Timeline |
|---|---|
| 64% hit target (n=14) | 46% on time (n=13) |
Journals published in (92)
Shown in this order: most published in first.
| Journal | Publications |
|---|---|
| Frontiers in psychology | 6 |
| European journal of psychotraumatology | 5 |
| Journal of consulting and clinical psychology | 5 |
| Journal of medical Internet research | 4 |
| PloS one | 4 |
Showing 5 of 92 journals.
Organization relationships (16)
Shown in this order: most evidence first.
| Related organization | Relationship | Evidence |
|---|---|---|
| Linkoeping University | Co sponsors trial with | 2 |
| 29k International AB | Co sponsors trial with | 1 |
| Swedish Council for Working Life and Social Research | Co sponsors trial with | 1 |
| European Association of Neurological Associations (EFNA) | Co sponsors trial with | 1 |
| Örebro University, Sweden | Co sponsors trial with | 1 |
Showing 5 of 16 relationships.
Latest dated events (76)
Shown in this order: newest first.
| Date | Event | Source |
|---|---|---|
| 2026-09-20 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-09 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-10 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-04-01 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
| 2026-02-19 | Trial started | Clinical trials (ClinicalTrials.gov) (ClinicalTrials.gov, U.S. National Library of Medicine; AACT database, Clinical Trials Transformation Initiative (CTTI)) |
Showing 5 of 76 events.
Biomarker capability evidence (8)
Shown in this order: tier desc, then gene symbol.
| Gene | Role | Evidence |
|---|---|---|
| HADH | Trial collaborator | Named in trial inclusion criteria |
| SPIN1 | Trial collaborator | Named in trial inclusion criteria |
| TFIP11 | Trial collaborator | Named in trial inclusion criteria |
| F3 | Trial collaborator | Named in trial exclusion criteria |
| F3 | Trial collaborator | Mentioned in trial text |
Showing 5 of 8 evidence rows.
Biomarkers this organization publishes on (273)
Shown in this order: most publications first.
Showing 5 of 273 biomarkers.
On Scientist.com
Stockholm University is listed as a research supplier in the Scientist.com network.
IFSU is a Core Facility for light- and electron-microscopy at Stockholm University established in 2009. The facility offers services to users of advanced imaging at Stockholm University as well as other institutions. We provide hands-on training and advice for experimental set ups and guide users to the most suitable instrument for their specific project. The following instruments are available at IFSU: Confocal microscopes; ZEISS LSM 780, ZEISS LSM 510 META, ZEISS LSM 510 Workstation with software (ZEN black 2011) for image processing Wide field Fluorescence microscope; Zeiss CELL OBSERVER...
Show the full description
IFSU is a Core Facility for light- and electron-microscopy at Stockholm University established in 2009. The facility offers services to users of advanced imaging at Stockholm University as well as other institutions. We provide hands-on training and advice for experimental set ups and guide users to the most suitable instrument for their specific project.
The following instruments are available at IFSU:
- Confocal microscopes; ZEISS LSM 780, ZEISS LSM 510 META, ZEISS LSM 510
- Workstation with software (ZEN black 2011) for image processing
- Wide field Fluorescence microscope; Zeiss CELL OBSERVER equipped for live cell imaging and microinjection
- Workstation with software for image processing including deconvolution
- Inverted fluorescence microscope Leica DM IRB
- Transmission electron microscope,TECNAI G2 Spirit Bio TWIN (FEI Company), 120 kV
Not on this page
Checked, with nothing recorded for this organization: companies grouped under this page, related companies not grouped here, active development programs, approved assets, us granted patents, sec-reported annual financials, financing and grant events, fda warning letters, fda untitled letters, fda inspection record, fda recalls, fda import refusals, manufacturing and distribution sites, climate targets, as filed, workforce and board diversity, as filed, and clia clinical laboratory certificates.
Work with Stockholm University - The Imaging Core on Scientist.com
For prices, more details, or to contact Stockholm University - The Imaging Core, visit Scientist.com.
Sign in to Scientist.com to open this supplier in your organization's marketplace.